Material Detail

"Parkinson's: Study reveals how cancer drug reduces toxic protein in brain" icon

Parkinson's: Study reveals how cancer drug reduces toxic protein in brain

An analysis of trial results reveals the mechanism through which the cancer drug nilotinib increases brain dopamine in people with Parkinson's disease.

Quality

  • User Rating
  • Comments
  • Learning Exercises
  • Bookmark Collection (1) Bookmark Collections
  • Course ePortfolios
  • Accessibility Info

More about this material

Comments

Log in to participate in the discussions or sign up if you are not already a MERLOT member.